EXOZ CCO Damien Perriman Receives 19,612 Shares via RSU Vest

What Happened Damien Perriman, Chief Commercial Officer of Exozymes, had 19,612 restricted stock units (RSUs vest) on August 19, 2026 that converted one-for-one into 19,612 shares of common stock (reported as an exercise/conversion of a derivative, code M). The filing also records a matching disposition of 19,612 shares at $0.00 (derivative), meaning these were not sold in the open market for cash; the reported cash value for the disposal is $0.00.

Key Details

• Transaction date: August 19, 2026; Form 4 filed August 25, 2026 (late filing relative to the transaction).
• Acquisition entry: 19,612 shares via exercise/conversion of derivative (RSU), acquisition price N/A (RSU conversion).
• Disposal entry: 19,612 shares @ $0.00 (derivative), reported value $0.00.
• Footnotes: RSUs convert one-for-one. On January 14, 2026 Perriman was granted 62,759 RSUs; the first vesting tranche occurred on August 19, 2026 for 19,612 shares.
• Shares owned after the transaction: not specified in the provided filing details.

Context This was a routine equity compensation event (RSU vesting and conversion), not an open-market purchase or sale. The $0.00 disposal typically indicates a non‑market internal settlement such as share surrender or withholding (e.g., for taxes or issuer retention) rather than a cash sale to a third party. Such vesting events reflect compensation being realized and do not by themselves signal insider buying or selling sentiment.